Skip to main content
Log in

Hepatic fat is superior to BMI, visceral and pancreatic fat as a potential risk biomarker for neurodegenerative disease

  • Magnetic Resonance
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

Prior studies relating body mass index (BMI) to brain volumes suggest an overall inverse association. However, BMI might not be an ideal marker, as it disregards different fat compartments, which carry different metabolic risks. Therefore, we analyzed MR-based fat depots and their association with gray matter (GM) volumes of brain structures, which show volumetric changes in neurodegenerative diseases.

Methods

Warp-based automated brain segmentation of 3D FLAIR sequences was obtained in a population-based study cohort. Associations of temporal lobe, cingulate gyrus, and hippocampus GM volume with BMI and MR-based quantification of visceral adipose tissue (VAT), as well as hepatic and pancreatic proton density fat fraction (PDFFhepatic and PDFFpanc, respectively), were assessed by linear regression.

Results

In a sample of 152 women (age 56.2 ± 9.0 years) and 199 men (age 56.1 ± 9.1 years), we observed a significant inverse association of PDFFhepatic and cingulate gyrus volume (p < 0.05) as well as of PDFFhepatic and hippocampus volume (p < 0.05), when adjusting for age and sex. This inverse association was further enhanced for cingulate gyrus volume after additionally adjusting for hypertension, smoking, BMI, LDL, and total cholesterol (p < 0.01) and also alcohol (p < 0.01). No significant association was observed between PDFFhepatic and temporal lobe and between temporal lobe, cingulate gyrus, or hippocampus volume and BMI, VAT, and PDFFpanc.

Conclusions

We observed a significant inverse, independent association of cingulate gyrus and hippocampus GM volume with hepatic fat, but not with other obesity measures. Increased hepatic fat could therefore serve as a marker of high-risk fat distribution.

Key Points

• Obesity is associated with neurodegenerative processes.

• In a population-based study cohort, hepatic fat was superior to BMI and visceral and pancreatic fat as a risk biomarker for decreased brain volume of cingulate gyrus and hippocampus.

• Increased hepatic fat could serve as a marker of high-risk fat distribution.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

AFNI:

Analyses of functional images

BMI:

Body mass index

FAST:

FMRIB’s automated segmentation tool

FLAIR:

Fluid attenuation inversion recovery

FLIR:

FMRIB’s linear registration tool

FMRIB:

Functional magnetic resonance imaging of the brain

FNIRT:

FMRIB’s non-linear image registration tool

GM:

Gray matter

KORA:

Cooperative Health Research in the Region of Augsburg

NAFLD:

Nonalcoholic fatty liver disease

PDFF:

Proton density fat fraction

TBV:

Total brain volume

VIBE:

Volume interpolated body examination

VAT:

Visceral adipose tissue

References

  1. Prickett C, Brennan L, Stolwyk R (2015) Examining the relationship between obesity and cognitive function: a systematic literature review. Obes Res Clin Pract 9:93–113

    Article  PubMed  Google Scholar 

  2. Cornier MA, Marshall JA, Hill JO, Maahs DM, Eckel RH (2011) Prevention of overweight/obesity as a strategy to optimize cardiovascular health. Circulation 124:840–850

    Article  PubMed  Google Scholar 

  3. Elias MF, Elias PK, Sullivan LM, Wolf PA, D'Agostino RB (2003) Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int J Obes Relat Metab Disord 27:260–268

    Article  CAS  PubMed  Google Scholar 

  4. Gunstad J, Paul RH, Cohen RA, Tate DF, Gordon E (2006) Obesity is associated with memory deficits in young and middle-aged adults. Eat Weight Disord 11:e15–e19

    Article  CAS  PubMed  Google Scholar 

  5. Gustafson D, Lissner L, Bengtsson C, Bjorkelund C, Skoog I (2004) A 24-year follow-up of body mass index and cerebral atrophy. Neurology 63:1876–1881

    Article  CAS  PubMed  Google Scholar 

  6. Bobb JF, Schwartz BS, Davatzikos C, Caffo B (2014) Cross-sectional and longitudinal association of body mass index and brain volume. Hum Brain Mapp 35:75–88

    Article  PubMed  Google Scholar 

  7. Dhikav V, Anand K (2011) Potential predictors of hippocampal atrophy in Alzheimer’s disease. Drugs Aging 28:1–11

    Article  CAS  PubMed  Google Scholar 

  8. Squire LR, Zola-Morgan S (1991) The medial temporal lobe memory system. Science 253:1380–1386

    Article  CAS  PubMed  Google Scholar 

  9. Driscoll I, Beydoun MA, An Y et al (2012) Midlife obesity and trajectories of brain volume changes in older adults. Hum Brain Mapp 33:2204–2210

    Article  PubMed  Google Scholar 

  10. Raji CA, Ho AJ, Parikshak NN et al (2010) Brain structure and obesity. Hum Brain Mapp 31:353–364

    PubMed  Google Scholar 

  11. Weible AP (2013) Remembering to attend: the anterior cingulate cortex and remote memory. Behav Brain Res 245:63–75

    Article  PubMed  Google Scholar 

  12. Hampson M, Driesen NR, Skudlarski P, Gore JC, Constable RT (2006) Brain connectivity related to working memory performance. J Neurosci 26:13338–13343

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Emmerzaal TL, Kiliaan AJ, Gustafson DR (2015) 2003–2013: a decade of body mass index, Alzheimer’s disease, and dementia. J Alzheimers Dis 43:739–755

    Article  PubMed  Google Scholar 

  14. Pedditizi E, Peters R, Beckett N (2016) The risk of overweight/obesity in mid-life and late life for the development of dementia: a systematic review and meta-analysis of longitudinal studies. Age Ageing 45:14–21

    Article  Google Scholar 

  15. Franzosi MG (2006) Should we continue to use BMI as a cardiovascular risk factor? Lancet 368:624–625

    Article  PubMed  Google Scholar 

  16. Despres JP (2006) Is visceral obesity the cause of the metabolic syndrome. Ann Med 38:52–63

    Article  CAS  PubMed  Google Scholar 

  17. Smits MM, van Geenen EJ (2011) The clinical significance of pancreatic steatosis. Nat Rev Gastroenterol Hepatol 8:169–177

    Article  PubMed  Google Scholar 

  18. Yang KC, Hung HF, Lu CW, Chang HH, Lee LT, Huang KC (2016) Association of non-alcoholic fatty liver disease with metabolic syndrome independently of central obesity and insulin resistance. Sci Rep 6:27034

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. VanWagner LB, Terry JG, Chow LS et al (2017) Nonalcoholic fatty liver disease and measures of early brain health in middle-aged adults: the CARDIA study. Obesity (Silver Spring) 25:642–651

    Article  CAS  Google Scholar 

  20. Whitmer RA, Gustafson DR, Barrett-Connor E, Haan MN, Gunderson EP, Yaffe K (2008) Central obesity and increased risk of dementia more than three decades later. Neurology 71:1057–1064

    Article  CAS  PubMed  Google Scholar 

  21. Holle R, Happich M, Lowel H, WichmannHE (2005) KORA--a research platform for population based health research. Gesundheitswesen 67(Suppl 1):S19–S25

    Article  Google Scholar 

  22. Bamberg F, Hetterich H, Rospleszcz S et al (2017) Subclinical disease burden as assessed by whole-body MRI in subjects with prediabetes, subjects with diabetes, and normal control subjects from the general population: the KORA-MRI study. Diabetes 66:158–169

    Article  CAS  PubMed  Google Scholar 

  23. World Health Organization (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. World Health Organization, Geneva

    Google Scholar 

  24. Ruf E, Baumert J, Meisinger C, Doring A, Ladwig KH (2014) Are psychosocial stressors associated with the relationship of alcohol consumption and all-cause mortality? BMC Public Health 14:312

  25. Hetterich H, Bayerl C, Peters A et al (2016) Feasibility of a three-step magnetic resonance imaging approach for the assessment of hepatic steatosis in an asymptomatic study population. Eur Radiol 26:1895–1904

    Article  PubMed  Google Scholar 

  26. Smith SM (2002) Fast robust automated brain extraction. Hum Brain Mapp 17:143–155

    Article  PubMed  PubMed Central  Google Scholar 

  27. Tzourio-Mazoyer N, Landeau B, Papathanassiou D et al (2002) Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15:273–289

    Article  CAS  PubMed  Google Scholar 

  28. Jenkinson M, Bannister P, Brady M, Smith S (2002) Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 17:825–841

    Article  PubMed  Google Scholar 

  29. Zhang C, Cahill ND, Arbabshirani MR, White T, Baum SA, Michael AM (2016) Sex and age effects of functional connectivity in early adulthood. Brain Connect 6:700–713

    Article  PubMed  PubMed Central  Google Scholar 

  30. Beller E, Keeser D, Wehn A et al (2018) T1-MPRAGE and T2-FLAIR segmentation of cortical and subcortical brain regions-an MRI evaluation study. Neuroradiology. https://doi.org/10.1007/s00234-018-2121-2

    Article  PubMed  Google Scholar 

  31. Wurslin C, Machann J, Rempp H, Claussen C, Yang B, Schick F (2010) Topography mapping of whole body adipose tissue using a fully automated and standardized procedure. J Magn Reson Imaging 31:430–439

    Article  PubMed  Google Scholar 

  32. Lorbeer R, Bayerl C, Auweter S et al (2017) Association between MRI-derived hepatic fat fraction and blood pressure in participants without history of cardiovascular disease. J Hypertens 35:737–744

    Article  CAS  PubMed  Google Scholar 

  33. Heber SD, Hetterich H, Lorbeer R et al (2017) Pancreatic fat content by magnetic resonance imaging in subjects with prediabetes, diabetes, and controls from a general population without cardiovascular disease. PLoS One 12:e0177154

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  34. Dell'Oglio E, Ceccarelli A, Glanz BI et al (2015) Quantification of global cerebral atrophy in multiple sclerosis from 3T MRI using SPM: the role of misclassification errors. J Neuroimaging 25:191–199

    Article  PubMed  Google Scholar 

  35. Hansen TI, Brezova V, Eikenes L, Haberg A, Vangberg TR (2015) How does the accuracy of intracranial volume measurements affect normalized brain volumes? Sample size estimates based on 966 subjects from the HUNT MRI cohort. AJNR Am J Neuroradiol 36:1450–1456

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Pintzka CW, Hansen TI, Evensmoen HR, Haberg AK (2015) Marked effects of intracranial volume correction methods on sex differences in neuroanatomical structures: a HUNT MRI study. Front Neurosci 9:238

    Article  PubMed  PubMed Central  Google Scholar 

  37. Gunstad J, Paul RH, Cohen RA et al (2008) Relationship between body mass index and brain volume in healthy adults. Int J Neurosci 118:1582–1593

    Article  PubMed  Google Scholar 

  38. Pannacciulli N, Del Parigi A, Chen K, Le DS, Reiman EM, Tataranni PA (2006) Brain abnormalities in human obesity: a voxel-based morphometric study. Neuroimage 31:1419–1425

    Article  PubMed  Google Scholar 

  39. Fox CS, Massaro JM, Hoffmann U et al (2007) Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 116:39–48

    Article  PubMed  Google Scholar 

  40. Cossrow N, Falkner B (2004) Race/ethnic issues in obesity and obesity-related comorbidities. J Clin Endocrinol Metab 89:2590–2594

    Article  CAS  PubMed  Google Scholar 

  41. Barlett HL, Puhl SM, Hodgson JL, Buskirk ER (1991) Fat-free mass in relation to stature: ratios of fat-free mass to height in children, adults, and elderly subjects. Am J Clin Nutr 53:1112–1116

    Article  CAS  PubMed  Google Scholar 

  42. Francque SM, van der Graaff D, Kwanten WJ (2016) Non-alcoholic fatty liver disease and cardiovascular risk: pathophysiological mechanisms and implications. J Hepatol 65:425–443

    Article  CAS  PubMed  Google Scholar 

  43. Wu S, Wu F, Ding Y, Hou J, Bi J, Zhang Z (2016) Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: a systematic review and meta-analysis. Sci Rep 6:33386

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Long MT, Wang N, Larson MG et al (2015) Nonalcoholic fatty liver disease and vascular function: cross-sectional analysis in the Framingham heart study. Arterioscler Thromb Vasc Biol 35:1284–1291

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Gorelick PB, Scuteri A, Black SE et al (2011) Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American heart association/American stroke association. Stroke 42:2672–2713

    Article  PubMed  PubMed Central  Google Scholar 

  46. Debette S, Seshadri S, Beiser A et al (2011) Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology 77:461–468

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Taipale T, Seppala I, Raitoharju E et al (2018) Fatty liver is associated with blood pathways of inflammatory response, immune system activation and prothrombotic state in Young Finns Study. Sci Rep 8:10358

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  48. Ghareeb DA, Hafez HS, Hussien HM, Kabapy NF (2011) Non-alcoholic fatty liver induces insulin resistance and metabolic disorders with development of brain damage and dysfunction. Metab Brain Dis 26:253–267

    Article  CAS  PubMed  Google Scholar 

  49. Sapmaz F, Uzman M, Basyigit S et al (2016) Steatosis grade is the Most important risk factor for development of endothelial dysfunction in NAFLD. Medicine (Baltimore) 95:e3280

    Article  Google Scholar 

  50. Stefan N, Haring HU (2013) The role of hepatokines in metabolism. Nat Rev Endocrinol 9:144–152

    Article  CAS  PubMed  Google Scholar 

  51. Weinstein G, Zelber-Sagi S, Preis SR et al (2018) Association of nonalcoholic fatty liver disease with lower brain volume in healthy middle-aged adults in the Framingham Study. JAMA Neurol 75:97–104

    Article  PubMed  Google Scholar 

  52. Sala M, van der Grond J, de Mutsert R et al (2016) Liver fat assessed with CT relates to MRI markers of incipient brain injury in middle-aged to elderly overweight persons. AJR Am J Roentgenol 206:1087–1092

    Article  PubMed  Google Scholar 

  53. Blaak E (2001) Gender differences in fat metabolism. Curr Opin Clin Nutr Metab Care 4:499–502

    Article  CAS  PubMed  Google Scholar 

  54. Karastergiou K, Smith SR, Greenberg AS, Fried SK (2012) Sex differences in human adipose tissues - the biology of pear shape. Biol Sex Differ 3:13

    Article  PubMed  PubMed Central  Google Scholar 

  55. Bos D, Leening MJG (2018) Leveraging the coronary calcium scan beyond the coronary calcium score. Eur Radiol 28:3082–3087

    Article  PubMed  PubMed Central  Google Scholar 

  56. Graffy PM, Pickhardt PJ (2016) Quantification of hepatic and visceral fat by CT and MR imaging: relevance to the obesity epidemic, metabolic syndrome and NAFLD. Br J Radiol 89:20151024

    Article  PubMed  PubMed Central  Google Scholar 

  57. Ajmera V, Park CC, Caussy C et al (2018) Magnetic resonance imaging proton density fat fraction associates with progression of fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology 155:307–310 e302

    Article  PubMed  Google Scholar 

  58. Idilman IS, Aniktar H, Idilman R et al (2013) Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology 267:767–775

    Article  PubMed  Google Scholar 

  59. Lindig T, Kotikalapudi R, Schweikardt D et al (2017) Evaluation of multimodal segmentation based on 3D T1-, T2- and FLAIR-weighted images - the difficulty of choosing. Neuroimage. https://doi.org/10.1016/j.neuroimage.2017.02.016

    Article  PubMed  Google Scholar 

Download references

Funding

This research was funded in-part by the German Research Foundation (DFG, Bonn, Germany; grant-number 245222810).​ The KORA study was initiated and financed by the Helmholtz Zentrum München—German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. The KORA-MRI sub-study was supported by an unrestricted research grant from Siemens Healthcare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ebba Beller.

Ethics declarations

Guarantor

The scientific guarantor of this publication is Sophia Stoecklein.

Conflict of interest

The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.

Statistics and biometry

No complex statistical methods were necessary for this paper.

Informed consent

Written informed consent was obtained from all subjects (patients) in this study.

Ethical approval

Institutional Review Board approval was obtained.

Methodology

• Retrospective

• Diagnostic or prognostic study

• Performed at one institution

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Beller, E., Lorbeer, R., Keeser, D. et al. Hepatic fat is superior to BMI, visceral and pancreatic fat as a potential risk biomarker for neurodegenerative disease. Eur Radiol 29, 6662–6670 (2019). https://doi.org/10.1007/s00330-019-06276-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-019-06276-8

Keywords

Navigation